<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate™ for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate

Formulation Development

We have formulation capabilities for liquid drug substance and lyophilized drug product for any protein

Copenhagen Lab - Analytical

Drug Formulation Development Services

Our formulation development experience enables us to provide innovative solutions to the specific challenges posed by your individual protein.

AGC Biologics develops formulations for liquid drug substance and drug product as well as lyophilized drug product (together with optimized lyophilization cycles).

We design broad, rapid excipient screening studies using Design of Experiment (DOE) principles to identify excipients and conditions consistent with maximum product stability.

We then systematically test these excipients and conditions in combination, using real-time and accelerated stability studies to deliver your perfect formulation.

  • Customized high-throughput fluorescent-based, pre-formulation screening

  • Formulations developed over a broad range of dose concentrations (micrograms to >175 mg/mL)

  • Wide array of analytical tools available to evaluate formulation stability, from HPLC to LC/MS peptide mapping


Interested in learning more?

Contact our team

View our Analytical, Formulation and Stability fact sheet

We pride ourselves on fast and flexible development to speed your product to market.